Viol Co Ltd
KOSDAQ:335890
Gross Margin
Viol Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
KR |
V
|
Viol Co Ltd
KOSDAQ:335890
|
487.4B KRW |
83%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
226B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.4B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
151.5B USD |
69%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
141.5B USD |
64%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.6B USD |
66%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.9B USD |
45%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.2B EUR |
38%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
79%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
64%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
61%
|
Viol Co Ltd
Glance View
VIOL Co., Ltd. is engaged in the provision of financial support services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-12-03. The firm's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The firm sells its products in domestic and overseas markets such as China and the United States.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Viol Co Ltd's most recent financial statements, the company has Gross Margin of 82.6%.